UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000010090
Receipt No. R000011766
Scientific Title Phase I study of Erlotinib and Crizotinib after ALK inhibitor failure in ALK positive advanced Non-Small Cell Lung Cancer
Date of disclosure of the study information 2013/02/21
Last modified on 2019/02/26 18:38:13

No. Disposal Last modified on Item of update
1 Insert 2013/02/21 13:23:06
2 Update 2014/10/04 20:44:06 TEL
Email
TEL
Name of person sending information
Name of person sending information
TEL
3 Update 2015/02/21 12:23:14 Email
4 Update 2018/06/14 12:55:07 Recruitment status
5 Update 2018/06/14 12:56:20 Name of primary sponsor
Organization
Email1
6 Update 2019/02/26 18:38:13 Recruitment status


Contact us.